This is a developing news story. Please check back soon for updates. Seonix Bio launched SightScore, a polygenic risk score ...

The metric has emerged as one of the strongest predictors of longevity and health, with research showing that higher VO2 max ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

With a single blood test at the time of arrival in the ED ... particularly when combined with serial troponin sampling over 1–3 hours and in conjunction with shared decision making. We acknowledge the ...

Objective High-sensitivity cardiac troponin I (hs-cTnI) is a novel biomarker of myocardial injury and ischaemia. Our objective was to ascertain correlates of hs-cTnI and its incremental prognostic ...

Cardiac troponin (cTn) is a highly specific biomarker of myocardial injury and is central to the diagnosis of acute myocardial infarction (AMI). By itself, however, cTn cannot identify the cause of ...

Objective: To evaluate the association of hypersensitive cardiac troponin (hs-cTnT), a biomarker of myocardial ... including peripheral neuropathy (as assessed by monofilament test), peripheral artery ...

While additional research is needed to test the possibility that combined use of the two ... Currently, around half of hospitals use troponin T and half troponin I, he added, with the choice most ...

The creators of a new test called “Humanity’s Last Exam” argue we may soon lose the ability to create tests hard enough for A.I. models. Credit...Rune Fisker Supported by By Kevin Roose ...

Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...